| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/17/2002 | US6451983 Tumor necrosis factor antibodies |
| 09/17/2002 | US6451982 Polypeptide with amino acid sequences grafted into human heavy and light chain variable regions |
| 09/17/2002 | US6451981 Inhibitor of cellular adhesion, migration or infiltration into areas of tissue damage, injury, or transplant |
| 09/17/2002 | US6451980 Antibody testing; obtain sample, incubate with binding particles, detect signal |
| 09/17/2002 | US6451979 Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies |
| 09/17/2002 | US6451977 Fused polypeptides |
| 09/17/2002 | US6451971 Polypeptide cell adhesion inhibitors; antimetastasis and anticarcinogenic agents |
| 09/17/2002 | US6451765 Methods for treating breast cancer using Mammastatin |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451760 Treatment of inflammation using a 2F1 polypeptide or an antibody thereto |
| 09/17/2002 | US6451599 Diagnosing arthritis, osteoarthritis, rheumatic disease, angiogenesis, cancer, atherosclerosis, kidney disease and inflammation |
| 09/17/2002 | US6451578 Hepatitis, amino acid sequences and nucleic acids |
| 09/17/2002 | US6451577 Human uridine disphosphate galactose-4-epimerase |
| 09/17/2002 | US6451575 The invention is directed to the family of aggrecan degrading metallo proteases (admps) that exhibit the ability to cleave the aggrecan core protein between amino acid residues glu.sup.373 -ala.sup.374. the invention encompasses the |
| 09/17/2002 | US6451562 Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides |
| 09/17/2002 | US6451561 Growth hormone variants |
| 09/17/2002 | US6451554 Purified nucleic acid sequence encoding a sodium channel protein wherein said nucleic acid sequence comprises the coding portion of the nucleic acid sequence and producing a mammalian sensory neuron sodium channel protein, wherein the |
| 09/17/2002 | US6451547 Process for differential diagnosis of Alzheimer's dementia and device therefor |
| 09/17/2002 | US6451545 Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method |
| 09/17/2002 | US6451541 Chaperones capable of binding to prion proteins and distinguishing the isoforms PrPc and PrPsc |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451523 Variant form of the receptor for the obese gene product. the invention relates to methods of detecting this receptor variant in cells and tissues of obese individuals. |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451324 Ryegrass pollen allergen |
| 09/17/2002 | US6451315 Compounds and methods for the diagnosis and treatment of B. microti infection |
| 09/17/2002 | US6451313 Heterotetramer; expression vectors encoding heavy and light chains; viricides |
| 09/17/2002 | US6451312 Diagnosis, imaging; induction of endothelial cell surface antigens |
| 09/17/2002 | US6451311 An antibody which binds procalcitonin but not free calcitonin, free katacalcin and free n-procalcitonin; used as an in vitro or in vivo diagnostic agent |
| 09/17/2002 | US6451310 Preventing t cell activation of b cells by administering antibody cabable of binding protein recognized by monoclonal antibody 5c8 |
| 09/17/2002 | US6451309 Prophylactic and therapeutic monoclonal antibodies |
| 09/17/2002 | US6451307 3′-exonuclease, production and use thereof |
| 09/17/2002 | US6451305 Methods for stimulating T cell responses to tumor cells expressing LFA-3 and a CD28 or CTLA4 ligand |
| 09/17/2002 | US6451284 Antibodies which target lymphoma cells which have a tendency to localize to the bone marrow. |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2204151C Cdna encoding a bmp type ii receptor |
| 09/17/2002 | CA2111853C Substantially pure receptor like tgf-.beta.1 binding molecules and uses thereof |
| 09/17/2002 | CA2067919C Heterobifunctional antibodies possessing dual catalytic and specific antigen binding properties and methods using them |
| 09/17/2002 | CA2047244C Genetically engineered immunoglobulins |
| 09/16/2002 | CA2373468A1 Reg-like protein |
| 09/13/2002 | CA2374027A1 Cloning, expression, sequencing, and functional enhancement of monoclonal scfv antibody against venezuelan equine encephalitis virus(vee) |
| 09/12/2002 | WO2002071060A2 Use of metabolic phenotyping in individualized treatment with amonafide |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070704A2 Adipocyte complement related protein zacrp11 |
| 09/12/2002 | WO2002070703A2 Cell visual characteristic-modifying sequences |
| 09/12/2002 | WO2002070700A1 Polynucleotide useful for modulating cancer cell proliferation |
| 09/12/2002 | WO2002070696A2 Cd109 nucleic acid molecules polypeptides and methods of use |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070657A2 93870, a human g-protein coupled receptor and uses therefor |
| 09/12/2002 | WO2002070655A2 Mouse cytokine receptor |
| 09/12/2002 | WO2002070648A2 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070553A1 Tumour peptide antigen produced from human mdm2 proto-oncogene |
| 09/12/2002 | WO2002070552A2 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF |
| 09/12/2002 | WO2002070010A1 Graft rejection inhibitors |
| 09/12/2002 | WO2002070009A1 Preventives/remedies for thickened scar, keloid or chronic arthritic diseases |
| 09/12/2002 | WO2002070008A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 09/12/2002 | WO2002070007A1 Methods of preventing or treating inflammatory or autoimmune disorders by administering integrin alphav beta3 antagonists |
| 09/12/2002 | WO2002070005A1 Compositions of multimeric profilin for diagnosis and treatment of allergies |
| 09/12/2002 | WO2002069908A2 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 09/12/2002 | WO2002069904A2 Cd2 antagonists for treatment of autoimmune or inflammatory disease |
| 09/12/2002 | WO2002069886A2 Modified proteins, designer toxins, and methods of making thereof |
| 09/12/2002 | WO2002063010A9 Method of producing recombinant antibodies against tumors |
| 09/12/2002 | WO2002062851A8 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 09/12/2002 | WO2002052012A3 Sugar beet genes involved in stress tolerance |
| 09/12/2002 | WO2002032375A8 Uses of monoclonal antibody 8h9 |
| 09/12/2002 | WO2002022680A3 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 09/12/2002 | WO2002014369A3 Human kininogen d5 domain polypeptides and their use |
| 09/12/2002 | WO2002012346A3 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 09/12/2002 | WO2001077335A3 Listeria monocytogenes genome, polypeptides and uses |
| 09/12/2002 | WO2001040519A3 Methods for identifying modulators for balance related disorders |
| 09/12/2002 | WO2001036626A9 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
| 09/12/2002 | WO2001035102A3 Diagnosis and treatment of malignant neoplasms |
| 09/12/2002 | WO2001030848A3 Nucleic acids of the human abc1 gene and applications thereof |
| 09/12/2002 | WO2001017557A9 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 09/12/2002 | WO2001016183A9 Monoclonal antibodies and vaccines against epitopes on the ebola virus glycoprotein |
| 09/12/2002 | WO2001010203A3 Non-human transgenic animals for the study of neurodegenerative syndromes |
| 09/12/2002 | WO2001009192A9 Human monoclonal antibodies to prostate specific membrane antigen |
| 09/12/2002 | WO2001006252A3 Prediction of hepatic failure following hepatitis c |
| 09/12/2002 | WO2001002609A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | WO2000073801A3 Breast, gastric and prostate cancer associated antigens and uses therefor |
| 09/12/2002 | WO2000067792A9 Monoclonal antibody directed against cells of human renal cell carcinoma |
| 09/12/2002 | WO2000066727A9 Tumour-associated antigen |
| 09/12/2002 | WO2000063435A3 Method of identifying toxic agents using differential gene expression |
| 09/12/2002 | US20020128464 Nucleotide sequences coding enzymatic polypeptide for use in generating geetically engineered herbicide sensitive plants |
| 09/12/2002 | US20020128459 Physiologically active protein originating in mammals |
| 09/12/2002 | US20020128453 Generating immunoglobulin; obtain blood sample, incubate with pepsin, remove decomposed products, recover immunoglobulins |
| 09/12/2002 | US20020128450 Amino acid sequence for use in the prevention and treatment of asthma, graft-versus-host disease, rheumatoid arthritis and sepsis |
| 09/12/2002 | US20020128449 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/12/2002 | US20020128448 Monoclonal antibody for use in the treatment of cell proliferative defects |
| 09/12/2002 | US20020128442 Human proteins STAM2a and STAM2b, and cDNAs encoding these molecules |
| 09/12/2002 | US20020128437 Polypeptide for use in the detection of bactericides and prevention, detect and treatment of infections |
| 09/12/2002 | US20020128200 Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for treating said individuals |